Laboratory changes and prognostic indicators of the adverse course of chronic heart failure with preserved left ventricular ejection fraction, excess weight and concomitant atrial fibrillation

Authors

DOI:

https://doi.org/10.14739/2310-1237.2022.3.268186

Keywords:

laboratory changes, prognosis, chronic heart failure, preserved ejection fraction, overweight, adiposity, atrial fibrillation

Abstract

Aim. To investigate the peculiarities of clinical and laboratory changes and to identify prognostic indicators of the adverse course of chronic heart failure with preserved left ventricular ejection fraction (CHFprEF), excess weight and concomitant atrial fibrillation (AF).

Materials and methods. The open, prospective, cohort study in parallel groups included 248 patients with CHFprEF, overweight and abdominal obesity, average age 65.0 ± 11.0 years; 146 (58.9 %) women and 102 (41.1 %) men. The first group included 181 patients with CHFprEF and excess weight without concomitant AF, and the second group – 67 CHFprEF patients with excess weight and AF. The complex clinical examination was performed according to the standards, including complaints, medical and family history, clinical, laboratory and instrumental examinations.

Results. It has been established that patients with CHFprEF and overweight or abdominal obesity concomitant AF have a predisposition to anemia, which was manifested by significant lower indicators of hemoglobin and erythrocytes in parallel with lower values of lymphocytes, more pronounced signs of systemic inflammation, dysfunction of the kidneys and liver with manifestations of cholestasis, which indicated deeper functional and structural disorders of organs and systems. ROC-analysis of the patients with CHFprEF, excess weight and concomitant AF demonstrated increase in the clinical endpoints rate for patients with BMI ˃32 kg/m2, the waist circumference / hips circumference ratio ˃1.1 U, leucocytes level ˃6 × 109 l, serum creatinine ˃96 mcmol/l, urea ˃7.3 mmol/l, glomerular filtration rate ≤65 ml/min/1.73 m2, LDL / HDL cholesterol ratio ˃2.05 U. The 5-years death predictors were found in patients with CHFprEF, excess weight and concomitant AF: functional class of CHF ˃ІІ, HDL cholesterol ≤0.9 mmol/l, LDL cholesterol ≤0.66 mmol/l and triglycerides ≤1.45 mmol/l; additionally, there were defined the predictors of recurrent admission to hospital with the CHFprEF decompensation: leucocytes level ˃6 × 109 l, LDL cholesterol ˃2.49 mmol/l, the LDL / HDL cholesterol ratio ˃2.05 U and the atherogenic ratio ˃2.91 U.

Conclusions. In patients with CHFprEF and excess weight, concomitant AF was associated with more severe laboratory changes, which reflected deeper functional and structural disorders of organs and systems. Laboratory predictors of the adverse course of CHFprEF in this category of patients have been established.

Author Biographies

P. P. Bidzilya, Zaporizhzhia State Medical University, Ukraine

MD, PhD, DSc, Associate Professor of the Department of Internal Diseases 1 and Simulation Medicine

V. H. Kadzharian, Zaporizhzhia State Medical University, Ukraine

MD, PhD, Associate Professor of the Department of Internal Medicine 1 and Simulation Medicine

References

Thygesen, L. C., Zinckernagel, L., Dalal, H., Egstrup, K., Glümer, C., Grønbæk, M., Holmberg, T., Køber, L., la Cour, K., Nakano, A., Nielsen, C. V., Sibilitz, K. L., Tolstrup, J. S., Zwisler, A. D., & Taylor, R. S. (2022). Cardiac rehabilitation for patients with heart failure: association with readmission and mortality risk. European heart journal. Quality of care & clinical outcomes, 8(8), 830-839. https://doi.org/10.1093/ehjqcco/qcab086

Rucker, D., & Joseph, J. (2022). Defining the Phenotypes for Heart Failure With Preserved Ejection Fraction. Current heart failure reports, 19(6), 445-457. https://doi.org/10.1007/s11897-022-00582-x

Borlaug B. A. (2020). Evaluation and management of heart failure with preserved ejection fraction. Nature reviews. Cardiology, 17(9), 559-573. https://doi.org/10.1038/s41569-020-0363-2

Ma, C., Luo, H., Fan, L., Liu, X., & Gao, C. (2020). Heart failure with preserved ejection fraction: an update on pathophysiology, diagnosis, treatment, and prognosis. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 53(7), e9646. https://doi.org/10.1590/1414-431X20209646

Del Buono, M. G., Iannaccone, G., Scacciavillani, R., Carbone, S., Camilli, M., Niccoli, G., Borlaug, B. A., Lavie, C. J., Arena, R., Crea, F., & Abbate, A. (2020). Heart failure with preserved ejection fraction diagnosis and treatment: An updated review of the evidence. Progress in cardiovascular diseases, 63(5), 570-584. https://doi.org/10.1016/j.pcad.2020.04.011

Yamashina, A., Nishikori, M., Fujimito, H., & Oba, K. (2022). Identification of predictive factors interacting with heart rate reduction for potential beneficial clinical outcomes in chronic heart failure: A systematic literature review and meta-analysis. International journal of cardiology. Heart & vasculature, 43, 101141. https://doi.org/10.1016/j.ijcha.2022.101141

Truby, L. K., & Rogers, J. G. (2020). Advanced Heart Failure: Epidemiology, Diagnosis, and Therapeutic Approaches. JACC. Heart failure, 8(7), 523-536. https://doi.org/10.1016/j.jchf.2020.01.014

Sciomer, S., Moscucci, F., Salvioni, E., Marchese, G., Bussotti, M., Corrà, U., & Piepoli, M. F. (2020). Role of gender, age and BMI in prognosis of heart failure. European journal of preventive cardiology, 27(2_suppl), 46-51. https://doi.org/10.1177/2047487320961980

Elagizi, A., Carbone, S., Lavie, C. J., Mehra, M. R., & Ventura, H. O. (2020). Implications of obesity across the heart failure continuum. Progress in cardiovascular diseases, 63(5), 561-569. https://doi.org/10.1016/j.pcad.2020.09.005

Reddy, Y., Obokata, M., Verbrugge, F. H., Lin, G., & Borlaug, B. A. (2020). Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation. Journal of the American College of Cardiology, 76(9), 1051-1064. https://doi.org/10.1016/j.jacc.2020.07.009

Taniguchi, N., Miyasaka, Y., Suwa, Y., Harada, S., Nakai, E., & Shiojima, I. (2020). Heart Failure in Atrial Fibrillation - An Update on Clinical and Echocardiographic Implications. Circulation journal, 84(8), 1212-1217. https://doi.org/10.1253/circj.CJ-20-0258

Mykhailovskyi, Ya. M. (2022). Vplyv klinichnykh i henetychnykh chynnykiv na stabilnist antykoahuliatsii varfarynom u khvorykh iz fibryliatsiieiu peredserd [The influence of clinical and genetic factors on the stability of warfarin’s anticoagulant effect in patients with atrial fibrillation]. Pathologia, 19(1), 12-17. [in Ukrainian]. https://doi.org/10.14739/2310-1237.2022.1.252662

Kolesnyk, M. Y., Mykhailovskyi, Y. M. (2021). The interrelation of CYP2C9, CYP4F2, VKORC1 genes polymorphisms with warfarin dose and hemorrhagic complications risk rise in patients with atrial fibrillation: a retrospective study. East European scienetific journal, 1(1), 37-43.

Kolesnyk, M. Yu., Kamyshnyi, О. М., & Mykhailovskyi, Ya. M. (2018). Vzaiemozviazok polimorfizmu heniv CYP2C9, CYP4F2, VKORC1 z rozvytkom hemorahichnykh uskladnen pry terapii varfarynom u khvorykh z fibryliatsiieiu peredserd: rezultaty odnotsentrovoho richnoho sposterezhennia [The interrelation of CYP2C9, CYP4F2, VKORC1 genes polymorphism and hemorrhagic complications of warfarin therapy in patients with atrial fibrillation: a single-center one-year study]. Ukrainskyi kardiolohichnyi zhurnal, (1), 54-59. [in Ukrainian].

Freedman, B., Hindricks, G., Banerjee, A., Baranchuk, A., Ching, C. K., Du, X., Fitzsimons, D., Healey, J. S., Ikeda, T., Lobban, T. C. A., Mbakwem, A., Narasimhan, C., Neubeck, L., Noseworthy, P., Philbin, D. M., Jr, Pinto, F. J., Rwebembera, J., Schnabel, R. B., Svendsen, J. H., Aguinaga, L., … Stepinska, J. (2021). World Heart Federation Roadmap on Atrial Fibrillation - A 2020 Update. Global heart, 16(1), 41. https://doi.org/10.5334/gh.1023

Ahn, M. S., Yoo, B. S., Yoon, J., Lee, S. H., Kim, J. Y., Ahn, S. G., Youn, Y. J., Lee, J. W., Son, J. W., Kim, H. S., Kang, D. R., Cho, H. J., Lee, H. Y., Jeon, E. S., Kang, S. M., Choi, D. J., & Cho, M. C. (2020). Guideline-directed therapy at discharge in patients with heart failure and atrial fibrillation. Heart (British Cardiac Society), 106(4), 292-298. https://doi.org/10.1136/heartjnl-2019-315240

Bavishi, A., & Patel, R. B. (2020). Addressing Comorbidities in Heart Failure: Hypertension, Atrial Fibrillation, and Diabetes. Heart failure clinics, 16(4), 441-456. https://doi.org/10.1016/j.hfc.2020.06.005

Ishigami, J., Grams, M. E., Naik, R. P., Caughey, M. C., Loehr, L. R., Uchida, S., Coresh, J., & Matsushita, K. (2018). Hemoglobin, Albuminuria, and Kidney Function in Cardiovascular Risk: The ARIC (Atherosclerosis Risk in Communities) Study. Journal of the American Heart Association, 7(2), e007209. https://doi.org/10.1161/JAHA.117.007209

McGranaghan, P., Saxena, A., Düngen, H. D., Rubens, M., Appunni,S., Salami, J., Veledar, E., Lacour, P., Blaschke, F., Obradovic, D., Loncar, G., Tahirovic, E., Edelmann, F., Pieske, B., & Trippel, T. D. (2021). Performance of a cardiac lipid panel compared to four prognostic scores in chronic heart failure. Scientific reports, 11(1), 8164. https://doi.org/10.1038/s41598-021-87776-w

Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J., Coats, A., Falk, V., González-Juanatey, J. R., Harjola, V. P., Jankowska, E. A., Jessup, M., Linde, C., Nihoyannopoulos, P., Parissis, J. T., Pieske, B., Riley, J. P., Rosano, G., Ruilope, L. M., Ruschitzka, F., Rutten, F. H., … ESC Scientific Document Group (2016). 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European heart journal, 37(27), 2129-2200. https://doi.org/10.1093/eurheartj/ehw128

Voronkov, L. H., Amosova, K. M., Dziak, H. V., Zharinov, O. Y., Kovalenko, V. M., Korkushko, O. V., Nesukai, O. H., Sychov, O. S., Rudyk, Yu. S., & Parkhomenko, O. M. (2017). Rekomendatsii Asotsiatsii kardiolohiv Ukrainy z diahnostyky ta likuvannia khronichnoi sertsevoi nedostatnosti (2017) [Guidelines of the Ukrainian Association of Cardiology for the Diagnosis and Treatment of Chronic Heart Failure (2017)]. Sertseva nedostatnist ta komorbidni stany, (1, Suppl_1), 1-66. [in Ukrainian].

Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G. A., Dilaveris, P. E., Fauchier, L., Filippatos, G., Kalman, J. M., La Meir, M., Lane, D. A., Lebeau, J. P., Lettino, M., Lip, G., Pinto, F. J., Thomas, G. N., ESC Scientific Document Group (2021). 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). European heart journal, 42(5), 373-498. https://doi.org/10.1093/eurheartj/ehaa612

Cunha, F. M., Pereira, J., Ribeiro, A., Silva, S., Araújo, J. P., Leite-Moreira, A., Bettencourt, P., & Lourenço, P. (2019). The cholesterol paradox may be attenuated in heart failure patients with diabetes. Minerva medica, 110(6), 507-514. https://doi.org/10.23736/S0026-4806.19.06067-1

Bidzilya P. P., Kadzharian V. H., Kapshytar N. I. (2021). Klinichnyi perebih i naslidky khronichnoi sertsevoi nedostatnosti zi zberezhenoiu fraktsiieiu livoho shlunochka na tli nadlyshkovoi masy tila ta ozhyrinnia z suputnoiu fibryliatsiieiu peredserd [Clinical course and outcomes of chronic heart failure with preserved left ventricular ejection fraction in concomitant overweight and obesity with comorbid atrial fibrillation]. Zaporozhye medical journal, 23(6), 778-783. [in Ukrainian]. https://doi.org/10.14739/2310-1210.2021.6.236247

Published

2023-01-27

How to Cite

1.
Bidzilya PP, Kadzharian VH. Laboratory changes and prognostic indicators of the adverse course of chronic heart failure with preserved left ventricular ejection fraction, excess weight and concomitant atrial fibrillation. Pathologia [Internet]. 2023Jan.27 [cited 2024Apr.16];19(3):201-6. Available from: http://pat.zsmu.edu.ua/article/view/268186

Issue

Section

Original research